Germany · Delayed Price · Currency is EUR Hofseth BioCare ASA Statistics
Total Valuation
FRA:HBQ has a market cap or net worth of EUR 49.08 million. The enterprise value is 69.84 million.
| Market Cap | 49.08M |
| Enterprise Value | 69.84M |
Important Dates
The last earnings date was Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 411.08M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 134.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.27 |
| PB Ratio | -7.69 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.13 |
| EV / Sales | 3.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -20.20 |
Financial Position
The company has a current ratio of 0.67
| Current Ratio | 0.67 |
| Quick Ratio | 0.37 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -7.35 |
| Interest Coverage | -4.92 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -19.14% |
| Return on Invested Capital (ROIC) | -30.83% |
| Return on Capital Employed (ROCE) | -73.40% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 288,770 |
| Profits Per Employee | -151,945 |
| Employee Count | 75 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 2.78 |
Taxes
In the past 12 months, FRA:HBQ has paid 14,870 in taxes.
| Income Tax | 14,870 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.67% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -60.67% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.13 |
| Relative Strength Index (RSI) | 48.84 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:HBQ had revenue of EUR 21.66 million and -11.40 million in losses. Loss per share was -0.03.
| Revenue | 21.66M |
| Gross Profit | 8.06M |
| Operating Income | -9.49M |
| Pretax Income | -11.38M |
| Net Income | -11.40M |
| EBITDA | -6.16M |
| EBIT | -9.49M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 5.66 million in cash and 25.41 million in debt, with a net cash position of -19.75 million.
| Cash & Cash Equivalents | 5.66M |
| Total Debt | 25.41M |
| Net Cash | -19.75M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -6.38M |
| Book Value Per Share | -0.02 |
| Working Capital | -6.71M |
Cash Flow
In the last 12 months, operating cash flow was -1.32 million and capital expenditures -2.14 million, giving a free cash flow of -3.46 million.
| Operating Cash Flow | -1.32M |
| Capital Expenditures | -2.14M |
| Free Cash Flow | -3.46M |
| FCF Per Share | n/a |
Margins
Gross margin is 37.21%, with operating and profit margins of -43.83% and -52.62%.
| Gross Margin | 37.21% |
| Operating Margin | -43.83% |
| Pretax Margin | -52.55% |
| Profit Margin | -52.62% |
| EBITDA Margin | -28.45% |
| EBIT Margin | -43.83% |
| FCF Margin | n/a |
Dividends & Yields
FRA:HBQ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.04% |
| Shareholder Yield | -0.04% |
| Earnings Yield | -23.22% |
| FCF Yield | -7.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |